Samsung upcycles old Galaxy phones for eye care

Article

Used smartphones attach to handheld fundus cameras to become eye care devices in developing countries

Samsung’s Galaxy Upcycling Program will repurpose old Galaxy smartphones into medical diagnosis cameras helping underserved populations in Vietnam, India, Morocco, and Papua New Guinea.

The company partnered with the International Agency for the Prevention of Blindness (IAPB) and Yonsei University Health System (YUHS) in Korea to create the medical devices used in its program.1

The tools are created by attaching smartphones to a handheld fundus camera, called Eyelike, designed by Samsung.1 Eyelike comes with a lens attachment for fundus diagnosis, according to the company.

The World Health Organization (WHO) reports at least 2.2 billion people around the globe have a form of vision impairment, and close to half of these cases are preventable or have yet to be addressed.2

“People around the globe face barriers to accessing fundamental health care, and we saw an opportunity to engineer smart, innovative solutions that reuse products to drive more sustainable practices and make a positive impact in our communities,” says Sung-Koo Kim, vice president of sustainability management office, mobile communications business at Samsung Electronics, in a statement. “This program embodies Samsung’s belief that technology can enrich people’s lives and help us build a more equitable and sustainable future for all.”

Eyelike cameras are being distributed to workers in low-income regions, the company says.

References

1. Samsung’s EYELIKE fundus camera repurposes Galaxy smartphones to improve access to eye care. Samsung Newsroom. April 7, 2021. Accessed April 26, 2021. https://news.samsung.com/global/samsungs-eyelike-fundus-camera-repurposes-galaxy-smartphones-to-improve-access-to-eye-care

2. Blindness and vision impairment. World Health Organization. February 26, 2021. Accessed April 26, 2021. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment#:~:text=Globally%2C%20at%20least%202.2%20billion,uncorrected%20refractive%20errors%20and%20cataracts.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.